Study Information: HUMMINGBIRD

Important Information

If you are interested in applying for this study, please:

Read the study description and study information document.
Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Description

New Zealand Clinical Research is trialling an investigational medicine that could help people with Chronic Hepatitis D. This is an investigational medicine because it has not been approved by MedSafe or other drug regulatory authorities.

Hepatitis D (Delta) is the least common but most severe form of viral hepatitis. It is rare in New Zealand. It can’t multiply without the hepatitis B virus (HBV) and is therefore only found in people with HBV. [Hepatitis D virus infection can occur at the same time as Hepatitis B virus infection].

The investigational medicine, ABI-6250, may help people with Chronic Hepatitis D by preventing Hepatitis D and B virus from entering the liver cells.

This is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2024 FULL 21720) is being funded by Assembly Biosciences, Inc and has been approved by the Health and Disability Ethics Committee.

Requirements

Healthy Males and Females

Aged between 18 – 60 years
Are in good health.
BMI (Body Mass Index) between 18 – 32 kg/m2
Not currently taking any regular prescription medications or supplements
Non-smokers/vapers or Ex-smokers/vapers within 3 months allowed.

What is Involved?

Study Visits: 5-night stay + 3 clinic visits

Reimbursement: Up to $3,000 before tax

Important Documents

Important documents to download and read

Hummingbird SAD Visit Planner

Hummingbird SAD Study Information

Pre-screening Form

Personal details

Please provide your name, email and phone number so we can contact you

Name(Required)

Email(Required)

Contact Number(Required)

Medical questions

Covid disclaimer(Required)

Have you had any covid symptoms in the last 4 weeks or been in isolation?

Contraception(Required)

This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?

Previous studies(Required)

Have you previously participated in a study with NZCR or any other organisation?

Have you had any bacterial/viral/fungal infections in the last 2 months?(Required)

Do you have any history of medical conditions relating to:

Gilbert's syndrome(Required)

Do you have any history or current Gilbert's syndrome condition?

Blood donation(Required)

Have you received blood or plasma in the last 90 days? If yes please provide details

Allergy History(Required)

Do you have or had any allergies?

Vaccines(Required)

Have received any vaccination within last 2 weeks?

Medication history?(Required)

Are you currently taking any prescription medication, vitamins, traditional Chinese medicine or minerals?

Visit dates(Required)

Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.

Screening Conditions(Required)

Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?

Pre-screening form policy(Required)

I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.

I agree